rs762246186
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 4P and 4B. PP3_StrongBS2
The NM_001376.5(DYNC1H1):c.4651T>C(p.Phe1551Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,614,102 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001376.5 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant childhood-onset proximal spinal muscular atrophy without contracturesInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Genomics England PanelApp
- intellectual disability, autosomal dominant 13Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)
- neuronopathy, distal hereditary motorInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- Charcot-Marie-Tooth disease axonal type 2OInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- autosomal dominant non-syndromic intellectual disabilityInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152210Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000278 AC: 7AN: 251488 AF XY: 0.0000294 show subpopulations
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461892Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 727248 show subpopulations
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152210Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74358 show subpopulations
ClinVar
Submissions by phenotype
Charcot-Marie-Tooth disease axonal type 2O Uncertain:1
In summary, this variant is a rare missense change with uncertain impact on protein function. There is no indication that it causes disease, but the available evidence is currently insufficient to prove that conclusively. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant is present in population databases (rs762246186, ExAC 0.009%) but has not been reported in the literature in individuals with a DYNC1H1-related disease. This sequence change replaces phenylalanine with leucine at codon 1551 of the DYNC1H1 protein (p.Phe1551Leu). The phenylalanine residue is highly conserved and there is a small physicochemical difference between phenylalanine and leucine. -
Inborn genetic diseases Uncertain:1
The c.4651T>C (p.F1551L) alteration is located in exon 22 (coding exon 22) of the DYNC1H1 gene. This alteration results from a T to C substitution at nucleotide position 4651, causing the phenylalanine (F) at amino acid position 1551 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
DYNC1H1-related disorder Uncertain:1
The DYNC1H1 c.4651T>C variant is predicted to result in the amino acid substitution p.Phe1551Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0062% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/14-102468982-T-C). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Intellectual disability, autosomal dominant 13 Uncertain:1
This sequence variant is a single nucleotide substitution (T>C) at position 4651 of the coding sequence of the DYNC1H1 gene that results in a phenylalanine to leucine amino acid change at residue 1551 of the DYNC1H1 protein. The Phe1551 residue falls in the linker domain which plays a critical role in the powerstroke movement of the DYNC1H1 protein (PMID: 32788638). This is a previously reported variant (ClinVar) that has not been observed in individuals with a DYNC1H1-related disorder in the published literature, to our knowledge. This variant is present in control population datasets (gnomAD database, 7 of 251,488 alleles, 0.003%). Multiple bioinformatic tools predict that this phenylalanine to leucine amino acid change would be damaging, and the Phe1551 residue is strongly conserved across the vertebrate species examined. Studies examining the functiol consequence of this variant have not been published, to our knowledge. At this time, there is insufficient evidence to determine if this variant is pathogenic or benign. Therefore, we consider this a variant of uncertain significance. ACMG Criteria: PM2, PP3 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at